Topic

Drug safety

Drug safety teams need timely visibility into regulator safety communications, labeling orders, and emerging product risks. This topic page surfaces PV Bulletin briefings tagged to drug safety themes, with practical implications for signal validation, label governance, and QPPV review.

2 matching updates · Sorted by impact priority

publicTga · Australia · Updated May 22, 2026

TGA safety updates add warnings for GLP-1s, fluoroquinolones, RSV vaccines

Urgency: Medium

Tga update requires triage for Label Governance, Signal Validation, Risk Management; confirm local obligations and document follow-up actions.

Label GovernanceSignal ValidationLocal Safety Officer

SOP Impact6 SOPs

ConfidenceMedium

Relevant for: Local Safety Officer, Signal Management Lead, Labeling Lead

verifiedRegulatory action: Regulators

Read impact briefarrow_forward

publicUpdated May 21, 2026

WSJ: Japan adds new warnings for Amgen’s Tavneos after deaths

Urgency: Medium

This update requires triage for Label Governance, Signal Validation, Risk Management; confirm local obligations and document follow-up actions.

Label GovernanceSignal ValidationSignal Management Lead

SOP Impact5 SOPs

ConfidenceMedium

Relevant for: Signal Management Lead, Labeling Lead, PV Technology / CSV Lead

verifiedRegulatory action: Latest

Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only

Drug Safety Alerts & Pharmacovigilance Briefings | PV Bulletin